Anar al contingut
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Tots els camps
Títol
Autor
Matèria
Signatura
ISBN/ISSN
Etiqueta
Trobar
Avançada
The Duffy antigen receptor for...
Citar
Enviar aquest missatge de text
Enviar per correu electrònic aquest
Imprimir
Exportar registre
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enllaç permanent
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression.
Dades bibliogràfiques
Autors principals:
Walley, N
,
Julg, B
,
Dickson, S
,
Fellay, J
,
Ge, D
,
Walker, B
,
Carrington, M
,
Cohen, MS
,
de Bakker, P
,
Goldstein, D
,
Shianna, K
,
Haynes, B
,
Letvin, N
,
Mcmichael, A
,
Michael, N
,
Weintrob, A
Format:
Journal article
Idioma:
English
Publicat:
2009
Fons
Descripció
Ítems similars
Visualització del personal
Ítems similars
Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.
per: Petrovski, S, et al.
Publicat: (2011)
Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1)/Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele.
per: Melissa B Davis, et al.
Publicat: (2015-01-01)
Neutrophil Effector Functions Are Not Impaired in Duffy Antigen Receptor for Chemokines (DARC)-Null Black South Africans
per: Kewreshini K. Naidoo, et al.
Publicat: (2019-03-01)
Duffy antigen receptor for chemokine (DARC) polymorphisms and its involvement in acquisition of inhibitory anti-duffy binding protein II (DBPII) immunity.
per: Flávia A Souza-Silva, et al.
Publicat: (2014-01-01)
CCL3L1 and HIV/AIDS susceptibility.
per: Urban, T, et al.
Publicat: (2009)